Ulcerative Colitis Drug Market by 2032
The Ulcerative Colitis (UC) drug market reached a size of USD 7.98 Billion in 2022 and is anticipated to achieve USD 13.48 Billion by 2032, with a projected revenue compound annual growth rate (CAGR) of 6% throughout the forecast period. Ulcerative Colitis is a chronic inflammatory condition impacting both the large intestine (colon) and rectum. […]